Laurion Capital Management LP Global Blood Therapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $10.5 Million - $13.7 Million	-268,846 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $5.66 Million - $9.59 Million	150,381 Added 126.94%	268,846 $11.6 Million
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $5.25 Million - $7.41 Million	99,527 Added 525.54%	118,465 $6.53 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $922,848 - $1.55 Million	18,938 New	18,938 $1.2 Million
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $1.89 Million - $3.39 Million	-41,391 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $1.88 Million - $2.4 Million	41,391 New	41,391 $2.01 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.